LATAM Technology Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Technology Reporter.

Press releases published on August 11, 2026

PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101
Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights
Astrotech Announces Plans for LP&L to Develop a Commercial Lunar Electric Utility
Compunnel Doubles Down on its Digital Business to Lead the Enterprise AI Shift
Coder Ranked No. 525 on the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies
Clearmind Medicine Announces Positive Permeation Results for Intranasal MEAI Formulation, Supporting Enhanced Nasal Retention Without Compromising Drug Delivery
Blue Mountain Ranks on Inc. 5000 List of Fastest Growing Private Companies For Second Year
Moody’s Ratings Upgrades Teva to Investment Grade, Reflecting the Ongoing Execution of Pivot to Growth Strategy
Nu-Tek BioSciences erhält zum dritten Mal in Folge die EcoVadis-Bronzeauszeichnung und baut seine Position als nachhaltiger Partner der Biopharmaindustrie weiter aus
Nu-Tek BioSciences Earns EcoVadis Bronze Rating for Third Consecutive Year, Strengthening Sustainable Biopharmaceutical Supplier Status
Nu-Tek BioSciences obtient la Médaille de bronze décernée par EcoVadis pour la troisième année consécutive, consolidant ainsi son statut de fournisseur biopharmaceutique respectueux de l’environnement
SlashExperts Launches Carly, an AI Agent That Turns Customers Into Your Best Sellers
Reflex Advanced Announces Strategic Review
LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
AdvanceIQ.ai Launches ARIA, Bringing AI Decision Intelligence to SMB Lenders
NovelMed Advances Its Ocular Program, Highlighting the Potential of a Single Therapy Across Multiple Retinal Diseases
Airia Wins Gold in 2026 Merit Awards for Business Innovation
MDaudit Ranked the 232nd Fastest-Growing Private Healthcare & Medical Company on the Inc. 5000
Gibson Oncology Announces First Patient Completes Initial Treatment Cycle in Phase II Trial of LMP744 for Recurrent Glioblastoma
Theriva™ Biologics Reports Second Quarter 2026 Operational Highlights and Financial Results

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

LATAM Technology Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.